Ftse Mib
33.609,85
-2,18%
DAX
18.265,68
-2,03%
S&P 500
5.433,74
0,23%
NASDAQ
17.667,56
0,34%
Bitcoin
66.703,18
-0,08%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Regulus Therapeutics Inc (RGLS) Regulus Therapeutics Inc (RGLS) Notizie

Regulus Therapeutics Inc

RGLS
2,52
0,155 (6,55%)
14 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/6/202414:00PRNUSRegulus Therapeutics Announces Expected Addition to the..
21/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/5/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:02EDGAR2Form 8-K - Current report
16/5/202414:00PRNUSRegulus Therapeutics Announces Promotion of Rekha Garg,..
09/5/202422:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:15EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSRegulus Therapeutics Reports First Quarter 2024 Financial..
06/5/202414:00PRNUSRegulus Therapeutics Advances to Cohort 4 of Phase 1b..
30/4/202414:00PRNUSRegulus Therapeutics to Participate in the Canaccord Genuity..
21/3/202421:05PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
12/3/202411:32PRNUSRegulus Therapeutics Announces Oversubscribed $100 Million..
12/3/202411:30PRNUSRegulus Therapeutics Announces Positive Topline Data from..
19/1/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202422:05PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
27/12/202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
22/11/202314:00PRNUSRegulus Therapeutics to Present at the 6th Annual Evercore..
09/11/202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05PRNUSRegulus Therapeutics Reports Third Quarter 2023 Financial..
02/11/202313:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Third..
19/10/202314:00PRNUSRegulus Therapeutics Advances to Cohort 3 of Phase 1b..
20/9/202313:00PRNUSRegulus Therapeutics Announces Positive Topline Data from..
13/9/202314:00PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
05/9/202314:00PRNUSRegulus Therapeutics Announces Participation at Two..
23/8/202314:00PRNUSRegulus Therapeutics to Host Virtual Investor Event on..
14/8/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:15EDGAR2Form 8-K - Current report
08/8/202322:05PRNUSRegulus Therapeutics Reports Second Quarter 2023 Financial..
Apertura: 2,37 Min: 2,35 Max: 2,56
Chiusura: 2,365

La tua Cronologia

NASDAQ
RGLS
Regulus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network